Skip to main content

Advertisement

SpringerLink
Log in

Antitumor effect of infrared whole-body hyperthermia with curcumin in breast Cancer

  • 1214: Multimedia Medical Data-driven Decision Making
  • Published:
Multimedia Tools and Applications Aims and scope Submit manuscript

Abstract

Infrared Hyperthermia therapy (IHT) is a non-contacting method to elevate body temperature and treat malignant lesions such as breast cancer. Breast cancer is one of the major cancer types among females and over the years, its prevalence is increasing. Current treatments of breast cancer are surgery, radiotherapy, chemotherapy and thermotherapy via the use of IHT or combination of these. IHT is most commonly combined with chemotherapy as its effect as a stand alone treatment platform is short lasting. However, chemotherapy induced toxicity to patients. Curcumin has traditionally been used as a food additive or as a remedy in traditional medicine for its anticancer and non-toxic effects. Thus, this research proposed the combination of curcumin and IHT as an alternative to chemotherapy in breast cancer treatment. Mice were inoculated with EMT6 breast cancer cells and assigned to 4 treatment groups: (i) untreated (control), (ii) orally curcumin (CUR), (iii) whole-body hyperthermia (FRWBH), (iv) orally curcumin with whole-body hyperthermia (FRWBH+CUR). Results showed that tumor growth inhibition and body weight gain in the combination treatment group (FRWBH+CUR) are significantly different compared to control. The group also had the longest median survival time (42 days) with no mortality observed during the experiment. This result indicates that the combination treatment is well tolerated by the mice and has negligible levels of toxicity. However, frequent complications of cancer such as anaemia and thrombocytopenia are still observed in the combination treatment group. Platelet to Lymphocyte Ratio (PLR) and Neutrophils to Lymphocytes Ratio (NLR) results indicate that the combination treatment (FRWBH+CUR) has better prognosis outcome than single treatment and may become a potential alternative antitumor treatment of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Abd Wahab NA, Lajis NH et al (2020) Mechanism of anti-Cancer activity of curcumin on androgen-dependent and androgen-independent prostate Cancer. Nutrients 12(3):679

    Google Scholar 

  2. Annapurna A, Suhasin G, Akondi RB, Jaya Prakash G, Ch SR (2011) Anti-cancer activity of Curcuma longa Linn.(turmeric). Journal of pharmacy research. J Pharm Res 4(4):1274–1276

    Google Scholar 

  3. Asea A, Ara G, Teicher BA, Stevenson M, Calderwood SK (2001) Effects of the flavonoid drug quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo. Int J Hyperth 17:347–356

    Google Scholar 

  4. Azab B, Shah N, Radbel J et al (2013) Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol 30(1):432

    Google Scholar 

  5. Azizah AM, Nor Saleha IT, Noor Hashimah A, Asmah ZA, Mastulu W (2016) Malaysian National Cancer Registry Report 2007-2011, Malaysia Cancer statistics, data and figure. Natl Cancer Inst 16:203

    Google Scholar 

  6. Bachmeier BE, Nerlich AG et al (2007) The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 19(1–4):137–152

    Google Scholar 

  7. Baronzio G, Parmar G, Ballerini M, Szasz A (2014) A brief overview of hyperthermia in Cancer treatment. J Integr Oncol 03(01):115

    Google Scholar 

  8. Bayet-Robert M, Kwitkowski F et al (2010 Jan) Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther 9(1):8–14

    Google Scholar 

  9. Behrouzkia Z, Joveini Z, Keshavarzi B, Eyvazzadeh N, Aghdam RZ (2016) Hyperthermia: how can it be used? Oman Medical Journal 31(2):89–97

    Google Scholar 

  10. Bettaieb A, Wrzal PK, Averill-bates DA (2013) Hyperthermia: Cancer treatment and beyond. Cancer Treat Innov Approaches B 2:257–283

    Google Scholar 

  11. Bimonte S, Barbieri A et al (2015) Dissecting the Role of Curcumin in Tumour Growth and Angiogenesis in Mouse Model of Human Breast Cancer, vol. 2015, pp. 16–20

  12. Birgegard G, Aapro MS et al (2005) Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology 68(SUPPL. 1):3–11

    Google Scholar 

  13. Bull JMC, Scott GL, Strebel FR, Nagle VL, Oliver D, Redwine M, Rowe RW, Ahn CW, Koch SM (2008) Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol. Int J Hyperth 24(8):649–662

    Google Scholar 

  14. Busti F, Marchi G, Ugolini S, Castagna A, Girelli D (2018 Dec) Anemia and Iron deficiency in Cancer patients: role of Iron replacement therapy. Pharmaceuticals (Basel) 11(4):94

    Google Scholar 

  15. Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, … Wolff AC (2009) Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw 7(2):122–192

    Google Scholar 

  16. Castaman G, Pieri L (2018) Management of thrombocytopenia in cancer. Thromb Res 164, no. February:S89–S93

    Google Scholar 

  17. Chen J, Deng Q, Pan Y, He B, Ying H, Sun H, Liu X, Wang S (2015) Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer. FEBS Open Bio 5:502–507

    Google Scholar 

  18. Conn JR, Catchpoole EM, Runnegar N, Mapp SJ, Markey KA (2017) Low rates of antibiotic resistance and infectious mortality in a cohort of high-risk hematology patients: a single center, retrospective analysis of blood stream infection. PLoS One 12(5):736–740

    Google Scholar 

  19. Decensi A, Costa A (2000) Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer. Eur J Cancer 36(6):694–709

    Google Scholar 

  20. Dutta S, Sengupta P (2016) Men and mice: relating their ages. Life Sci Elsevier Inc 152:244–248

    Google Scholar 

  21. Falah RR, Talib WH, Shbailat SJ (2017) Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis. Ther Adv Med Oncol 9(4):235–252

    Google Scholar 

  22. Falks MH, Issels RD (2001) Hyperthermia in oncology. Int J Hyperth 17(1):1–18

    Google Scholar 

  23. Farhangi B, Alizadeh AM et al (2015) Protective effects of dendrosomal curcumin on an animal metastatic breast tumor. Eur J Pharmacol 758:188–196

    Google Scholar 

  24. Ghasemzadeh A, Jaafar HZE, Rahmat A (2010) Antioxidant activities, total phenolics and flavonoids content in two varieties of Malaysia young ginger (Zingiber officinale roscoe). Molecules 15(6):4324–4333

    Google Scholar 

  25. Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as ‘Curecumin’: from kitchen to clinic. Biochem Pharmacol 75(4):787–809

    Google Scholar 

  26. Gorczynski RM, Chen Z, Diao J, Khatri I, Wong K, Yu K, Behnke J (2010) Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice. Breast Cancer Res Treat 123(2):405–415

    Google Scholar 

  27. Gu M et al (2016) Pre-treatment mean platelet volume associates with worse clinicopathologic features and prognosis of patients with invasive breast cancer. Breast Cancer 23:752–760

    Google Scholar 

  28. Harrison LB, Sasha LD et al (2000) Radiotherapy-associated Anemia : the scope of the problem. Oncologist 5(Suppl 2):1–7

    Google Scholar 

  29. Hattori T, Kokura S, Okuda T, Okayama T, Takagi T, Handa O, Naito Y, Yoshida N, Yoshikawa T (2007) Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer. Int J Hyperth 23(7):591–598

    Google Scholar 

  30. Herman TS, Teicher BA, Jochelson M, Clark J, Svensson G, Coleman CN (1988) Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int J Hyperth 4(2):143–158

    Google Scholar 

  31. Ismail M, Manickam E, Danial AM, Rahmat A, Yahaya A (2000) Chemical composition and antioxidant activity of Strobilanthes crispus leaf extract. J Nutr Biochem 11(11):536–542

    Google Scholar 

  32. Jia W et al (2015) The peripheral blood neutrophil-to-lymphocyte ratio is superior to the lymphocyte-to-monocyte ratio for predicting the long-term survival of triple-negative breast cancer patients. PLoS One 10(11):1–13

    Google Scholar 

  33. Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23(13):3079–3085

    Google Scholar 

  34. Jothy SL, Zakaria Z, Chen Y, Lau YL, Latha LY, Sasidharan S (2011) Acute oral toxicity of methanolic seed extract of Cassia fistula in mice. Molecules 16:5268–5282

    Google Scholar 

  35. Kirshner J, Hatch M, Hennessy DD, Fridman M, Tannous RE (2004) Anemia in stage II and III breast Cancer patients treated with adjuvant doxorubicin and cyclophosphamide chemotherapy. Oncologist 9(1):25–32

    Google Scholar 

  36. Kossatz S, Grandke J, Couleaud P, Latorre A, Aires A, Crosbie-Staunton K, Ludwig R, Dähring H, Ettelt V, Lazaro-Carrillo A, Calero M, Sader M, Courty J, Volkov Y, Prina-Mello A, Villanueva A, Somoza Á, Cortajarena AL, Miranda R, Hilger I (2015) Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Res 17:66

    Google Scholar 

  37. Lai HW, Chien SY et al (2012) The potential utility of curcumin in the treatment of HER-2-overexpressed breast Cancer: an in vitro and in vivo comparison study with Herceptin. Evidence-Based Complement Altern Med 2012:1–12

    Google Scholar 

  38. Lal I, Dittus K, Holmes CE (2013) Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Res 15(207):1–12

    Google Scholar 

  39. Lee H, Park HJ et al (2014) Response of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combined. PLoS One 9(2):e87979

    Google Scholar 

  40. Lee CL, Tsai CH et al (2016) Hemoglobin level trajectories in the early treatment period are related with survival outcomes in patients with breast cancer. Oncotarget 8(1):1569–1579

    Google Scholar 

  41. Liebman HA (2014) Thrombocytopenia in cancer patients. Thromb Res 133(SUPPL. 2):S63–S69

    Google Scholar 

  42. Lissoni P, Brivio F, Ferrante R, Vigore L, Vaghi M, Fumagalli E, Bucovec R, Malugani F, Fumagalli L (2000) Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer. Int J Biol Markers 15(1):22–25

    Google Scholar 

  43. Lv ZD, Liu XP, Zhao WJ, Dong Q, Li FN, Wang HB, Kong B (2014) Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. Int J Clin Exp Pathol 7(6):2818–2824

    Google Scholar 

  44. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC (2006) Multiple biological activities of curcumin: a short review. Life Sci 78(18):2081–2087

    Google Scholar 

  45. Maluta S, Kolff MW (2015) Role of hyperthermia in breast Cancer Locoregional recurrence: a review. Breast Care 10(6):408–412

    Google Scholar 

  46. Manikandan R, Beulaja M, Arulvasu C, Sellamuthu S, Dinesh D, Prabhu D, Babu G, Vaseeharan B, Prabhu NM (2012) Synergistic anticancer activity of curcumin and catechin: an in vitro study using human cancer cell lines. Microsc Res Tech 75(2):112–116

    Google Scholar 

  47. Mantas D, Kostakis ID, Machairas N, Markopoulos C (2016) White blood cell and platelet indices as prognostic markers in patients with invasive ductal breast carcinoma. Oncol Lett 12(2):1610–1614

    Google Scholar 

  48. Mariotto AB, Noone AM, Howlader N, Cho H, Keel GE, Garshell J, Woloshin S, Schwartz LM (2014) Cancer survival: an overview of measures, uses, and interpretation. J Natl Cancer Inst - Monogr 2014(49):145–186

    Google Scholar 

  49. Masuelli L, Benvenuto M, Fantini M, Marzocchella L, Sacchetti P, di Stefano E, Tresoldi I, Izzi V, Bernardini R, Palumbo C, Mattei M, Lista F, Galvano F, Modesti A, Bei R (2013) Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice. J Biol Regul Homeost Agents 27(1):105–119

    Google Scholar 

  50. Matsen CB, Neumayer LA (2006) Breast Cancer. PET Clin 1(1):2000

    Google Scholar 

  51. Mitha S, Nagarajan V, Babar MG, Siddiqui MJA, Jamshed SQ (2013) Reasons of using complementary and alternative medicines (CAM) among elderly Malaysians of Kuala Lumpur and Selangor states: an exploratory study. J Young Pharm 5(2):50–53

    Google Scholar 

  52. Mullauer FB, Kessler JH, Medema JP (2010) Betulinic acid, a natural compound with potent anticancer effects. Anti-Cancer Drugs 21(3):215–227

    Google Scholar 

  53. Muthana M, Multhoff G, Pockley AG (2010) Tumour infiltrating host cells and their significance for hyperthermia. Int J Hyperth 26(3):247–255

    Google Scholar 

  54. Nair PKR, Melnick SJ, Wnuk SF, Rapp M, Escalon E, Ramachandran C (2009) Isolation and characterization of an anticancer catechol compound from Semecarpus anacardium. J Ethnopharmacol 122(3):450–456

    Google Scholar 

  55. Nguyen N, Bellile E et al (2016) Tumor Infiltrating Lymphocytes and Survival in patients with head and neck squamous cell carcinoma. Head Neck 38(7):1074–1084

    Google Scholar 

  56. Nguyen N, Bellile E, Thomas D, McHugh J, Rozek L, Virani S, Peterson L, Carey TE, Walline H, Moyer J, Spector M, Perim D, Prince M, McLean S, Bradford CR, Taylor JMG, Wolf GT, Head and Neck SPORE Program Investigators (2016) Tumor infiltrating lymphocytes and survival in. Head Neck 38(7):1074–1084

    Google Scholar 

  57. Oh K, Lee OY et al (2013) A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model. Breast Cancer Res 15(5):R79

    Google Scholar 

  58. Okuturlar Y et al (2015) Utility of Peripheral Blood Parameters in Predicting Breast Cancer Risk. Asian Pac J Cancer Prev 16:2409–2412

    Google Scholar 

  59. Orditura M, Galizia G et al (2016) Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer : a propensity score-matched analysis. pp. 1–9

  60. Orditura M et al (2016) Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer : a propensity score-matched analysis. pp. 1–9

  61. Park B, Lee HS, Lee JW, Park S (2019) Association of white blood cell count with breast cancer burden varies according to menopausal status, body mass index, and hormone receptor status: a case-control study. Sci Rep 9(1):1–10

    Google Scholar 

  62. Pierce BL, Ballard-Barbash R et al (2009) Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients. J Clin Oncol 27(21):3437–3444

    Google Scholar 

  63. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D’Orsi C, Jong R, Rebner M, Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group (2005) Characteristics of eligible women and women whose cancer status was verified. N Engl Theatr J 353:1773–1784

    Google Scholar 

  64. Rakha EA, Lee AHS, Evans AJ, Menon S, Assad NY, Hodi Z, Macmillan D, Blamey RW, Ellis IO (2010) Tubular carcinoma of the breast: further evidence to support its excellent prognosis. J Clin Oncol 28(1):99–104

    Google Scholar 

  65. Rana APS, Kaur M, Zonunsanga B, Puri A, Kuka AS (2015) Preoperative Peripheral Blood Count in Breast Carcinoma: Predictor of Prognosis or a Routine Test. Int J Breast Cancer 2015:1–5

    Google Scholar 

  66. Repasky EA, Evan SS, Dewhirst MW (2013) Temperature matters! and why it should matter to tumor immunologist. Cancer Immunol Res 1(4):210–216

    Google Scholar 

  67. Robins HI, Longo WL et al (1988) Phase I Trial of Lonidamine with Whole Body Hyperthermia in Advanced Cancer 1, no. 17, pp. 6587–6592

  68. Rockwell S, Lew YF et al (2012) Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumors. Int J Radiat Biol 88(3):277–285

    Google Scholar 

  69. Rowe RW, Strebel SR et al (2010) Fever-range whole-body thermotherapy combined with Oxaliplatin: a curative regimen in a preclinical breast Cancer model. Int J Hyperth 26(6):565–576

    Google Scholar 

  70. Shankar A, Wang JJ, Rochtchina E, Yu MC, Kefford R, Mitchell P (2006) Association between circulating white blood cell count and cancer mortality. Arch Intern Med 166:188–194

    Google Scholar 

  71. Shen M, Hu P, Donskov F, Wang G, Liu Q, Du J (2014) Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS One 9(6):1–10

    Google Scholar 

  72. Shiri S, Alizadeh AM, Baradaran B, Farhanghi B, Shanehbandi D, Khodayari S, Khodayari H, Tavassoli A (2015) Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing M1/M2 macrophage balance in the tumor microenvironment. Asian Pac J Cancer Prev 16(9):3917–3922

    Google Scholar 

  73. Shrivastava S, Singh N, Nigam AK, Chandel SS, Shrivastava R, Kumar S (2016) Comparative study of hematological parameters along with the effect of chemotherapy and radiotherapy in different stages of breast cancer. Int J Res Med Sci 5(1):311

    Google Scholar 

  74. Smyth MJ, Dunn GP, Schreiber RD (2006) Cancer Immunosurveillance and Immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 90(06):1–50

    Google Scholar 

  75. Somers-Edgar TJ, Scandlyn MJ, Stuart EC, Le Nedelec MJ, Valentine SP, Rosengren RJ (2008) The combination of epigallocatechin gallate and curcumin suppresses ER??-breast cancer cell growth in vitro and in vivo. Int J Cancer 122(9):1966–1971

    Google Scholar 

  76. Sugahara T, Van der Zee J, Kampinga HH, Vujaskovic Z, Kondo M, Ohnishi T, Li G, Park HJ, Leeper DB, Ostapenko V, Repasky, E. a, Watanabe, M. and Song, C. W. (2008) Application of thermal stress for the improvement of health. Int J Hyperth 24(2):123–140

    Google Scholar 

  77. Talib WH, Saleh S (2015) Propionibacterium acnes augments antitumor, anti-angiogenesis and immunomodulatory effects of melatonin on breast cancer implanted in mice. PLoS One 10(4):1–13

    Google Scholar 

  78. Teicher BA, Herman TS, Holden SA (1988) Combined modality therapy with bleomycin, hyperthermia, and radiation. Cancer Res 48(22):6291–6297

    Google Scholar 

  79. Tomayko MM, Reynolds CP (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24:148–154

  80. Toyota N, Strebel FR, Stephens LC, Matsuda H, Oshiro T, Jenkins GN, Bull JMC (1998) Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin, combined with whole-body hyperthermia in a rat mammary adenocarcinoma. Int J Cancer 76(4):499–505

    Google Scholar 

  81. Ulas A, Avci N, Kos T, Cubukcu E, Olmez OF, Degirmenci M (2015) Neutrophil/lymphocyte and platelet/lymphocyte ratio as prognosticators in breast cancer 715, vol. 20, no. 3, pp. 714–722

  82. Ulas A, Avci N, Kos T, Cubukcu E, Olmez OF, Degirmenci M (n.d.) Neutrophil/lymphocyte and platelet/lymphocyte ratio as prognosticators in breast cancer 715, vol. 20, no. 3, pp. 714–722

  83. Uysal B (2018) Hyperthermia and breast cancer: a short review. J Radiol Oncol 1(3):079–082

    Google Scholar 

  84. Vincze G, Szasz O, Szasz A (2015) Generalization of the thermal dose of hyperthermia in oncology. Open J Biophys 5(5):97–114

    Google Scholar 

  85. Wang W et al (2016) The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis. Onco Targets Ther 9:5567–5575

    Google Scholar 

  86. Wei B, Yao M, Wang W et al (2016) The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis. Onco Targets Ther 9:5567–5575

    Google Scholar 

  87. Weigelt B, Reis-filho JS (2009) Reviews histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 6(12):718–730

    Google Scholar 

  88. Wondergem J, Stephens LC et al (1991) Effect of Adriamycin Combined with Whole Body Hyperthermia on Tumor and Normal Tissues, no. 9, pp. 3559–3567

  89. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM (2002) Review hyperthermia in combined treatment of cancer. Lancet Oncol 3(August):487–497

    Google Scholar 

  90. Yao M, Liu Y et al (2014) Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer. Onco Targets Ther 7:1743–1752

    Google Scholar 

  91. Yu X, Zhang Z, Wang Z, Wu P, Qiu F, Huang J (2016) Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis. Clin Transl Oncol 18(5):497–506

    Google Scholar 

  92. Zhou H, Beevers CS, Huang S (2011) The targets of curcumin. Curr Drug Targets 12(3):332–347

    Google Scholar 

  93. Zhou Q, Wang X, Liu X, Zhang H, Lu Y, Su S (2011) Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo. Acta Pharmacol Sin 32(11):1402–1410

    Google Scholar 

  94. Zhu Y, Si W, Sun Q, Qin B, Zhao W, Yang J (2017) Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer. Oncotarget 8(1):1023–1030

    Google Scholar 

  95. Zwiener I, Blettner M, Hommel G (2011) Survival analysis. Dtsch Arztebl Int 108(10):163–169

    Google Scholar 

Download references

Acknowledgements

This work was supported by Research University Grant 15H87 and 15J83 and High Impact Research Grant 04G47.

Author information

Authors and Affiliations

  1. EngineeringDiagnostics Research Group, School of Biomedical Engineering and Health Sciences, Faculty of Engineering,, Universiti Teknologi Malaysia, 81310, Johor Bahru, Johor, Malaysia

    Hanim Saim, Siti N. M. Yassin, Maheza I. M. Salim, Rania H. AlAshwal, Asnida A. Wahab & Mariaulpa Sahalan

  2. Faculty of Sciences, Universiti Teknologi Malaysia, 81310, Johor Bahru, Johor, Malaysia

    Khairunadwa Jemon

  3. Lee Kong Chian Faculty of Engineering and Sciences, Universiti Tun Abd Rahman, Cheras, Selangor, Malaysia

    Hum Yan Chai

  4. Faculty of Engineering, University of Malaya, 50603, Kuala Lumpur, Malaysia

    Lai K. Wee

Authors
  1. Hanim Saim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Siti N. M. Yassin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maheza I. M. Salim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Khairunadwa Jemon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rania H. AlAshwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Asnida A. Wahab
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mariaulpa Sahalan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hum Yan Chai
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lai K. Wee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Siti N. M. Yassin.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saim, H., Yassin, S.N.M., Salim, M.I.M. et al. Antitumor effect of infrared whole-body hyperthermia with curcumin in breast Cancer. Multimed Tools Appl 81, 41851–41868 (2022). https://doi.org/10.1007/s11042-022-13521-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11042-022-13521-8

Keywords

Search

Navigation